Overexpression of EphA2 correlates with epithelial–mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients
The expression of EphA2 and three epithelial–mesenchymal transition-related proteins (E-cadherin, β-catenin and vimentin) was detected by immunohistochemistry in human gastric cancer and normal gastric mucosa. The expression of EphA2 and vimentin was significantly higher in gastric cancer tissues th...
Saved in:
Published in | Medical oncology (Northwood, London, England) Vol. 29; no. 4; pp. 2691 - 2700 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Boston
Springer US
01.12.2012
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The expression of EphA2 and three epithelial–mesenchymal transition-related proteins (E-cadherin, β-catenin and vimentin) was detected by immunohistochemistry in human gastric cancer and normal gastric mucosa. The expression of EphA2 and vimentin was significantly higher in gastric cancer tissues than in normal gastric mucosa tissues, and similar results were found for negative E-cadherin expression and ectopic β-catenin expression. Further analysis showed that the expression of EphA2 was closely correlated with the depth of tumor invasion, tumor–node–metastasis (TNM) stages and lymph node metastasis. Down-regulated expression of the epithelial protein E-cadherin, overexpression of the mesenchymal protein vimentin and ectopic expression of β-catenin were associated with the depth of tumor invasion, tumor differentiation, TNM stages and lymph node metastasis. The Spearman rank test indicated that the positive expression of EphA2 was negatively associated with E-cadherin expression and was positively correlated with β-catenin ectopic expression and vimentin expression. In addition, the Kaplan–Meier survival analysis showed that the overexpression of EphA2 and vimentin, ectopic expression of β-catenin and down-regulation of E-cadherin indicate a poor outcome. Moreover, multivariate Cox analysis showed that TNM stages, lymph node metastasis, EphA2 expression, E-cadherin expression and β-catenin ectopic expression were independent prognostic factors for postoperative gastric cancer. These findings indicate that the overexpression of EphA2 correlates with the loss of epithelial proteins and the appearance of mesenchymal proteins. Therefore, EphA2 may play a role in epithelial–mesenchymal transition in gastric cancer. |
---|---|
AbstractList | The expression of EphA2 and three epithelial-mesenchymal transition-related proteins (E-cadherin, β-catenin and vimentin) was detected by immunohistochemistry in human gastric cancer and normal gastric mucosa. The expression of EphA2 and vimentin was significantly higher in gastric cancer tissues than in normal gastric mucosa tissues, and similar results were found for negative E-cadherin expression and ectopic β-catenin expression. Further analysis showed that the expression of EphA2 was closely correlated with the depth of tumor invasion, tumor-node-metastasis (TNM) stages and lymph node metastasis. Down-regulated expression of the epithelial protein E-cadherin, overexpression of the mesenchymal protein vimentin and ectopic expression of β-catenin were associated with the depth of tumor invasion, tumor differentiation, TNM stages and lymph node metastasis. The Spearman rank test indicated that the positive expression of EphA2 was negatively associated with E-cadherin expression and was positively correlated with β-catenin ectopic expression and vimentin expression. In addition, the Kaplan-Meier survival analysis showed that the overexpression of EphA2 and vimentin, ectopic expression of β-catenin and down-regulation of E-cadherin indicate a poor outcome. Moreover, multivariate Cox analysis showed that TNM stages, lymph node metastasis, EphA2 expression, E-cadherin expression and β-catenin ectopic expression were independent prognostic factors for postoperative gastric cancer. These findings indicate that the overexpression of EphA2 correlates with the loss of epithelial proteins and the appearance of mesenchymal proteins. Therefore, EphA2 may play a role in epithelial-mesenchymal transition in gastric cancer.[PUBLICATION ABSTRACT] The expression of EphA2 and three epithelial-mesenchymal transition-related proteins (E-cadherin, β-catenin and vimentin) was detected by immunohistochemistry in human gastric cancer and normal gastric mucosa. The expression of EphA2 and vimentin was significantly higher in gastric cancer tissues than in normal gastric mucosa tissues, and similar results were found for negative E-cadherin expression and ectopic β-catenin expression. Further analysis showed that the expression of EphA2 was closely correlated with the depth of tumor invasion, tumor-node-metastasis (TNM) stages and lymph node metastasis. Down-regulated expression of the epithelial protein E-cadherin, overexpression of the mesenchymal protein vimentin and ectopic expression of β-catenin were associated with the depth of tumor invasion, tumor differentiation, TNM stages and lymph node metastasis. The Spearman rank test indicated that the positive expression of EphA2 was negatively associated with E-cadherin expression and was positively correlated with β-catenin ectopic expression and vimentin expression. In addition, the Kaplan-Meier survival analysis showed that the overexpression of EphA2 and vimentin, ectopic expression of β-catenin and down-regulation of E-cadherin indicate a poor outcome. Moreover, multivariate Cox analysis showed that TNM stages, lymph node metastasis, EphA2 expression, E-cadherin expression and β-catenin ectopic expression were independent prognostic factors for postoperative gastric cancer. These findings indicate that the overexpression of EphA2 correlates with the loss of epithelial proteins and the appearance of mesenchymal proteins. Therefore, EphA2 may play a role in epithelial-mesenchymal transition in gastric cancer. |
Author | Wang, Jixu Huang, Jin Chen, Zhikang Qian, Liyuan Chen, Zihua Wu, Shaobin Chen, Jinxiang Ge, Jie Hou, Futao Yuan, Weijie |
Author_xml | – sequence: 1 givenname: Futao surname: Hou fullname: Hou, Futao organization: Department of General Surgery, Xiangya Hospital, Central South University – sequence: 2 givenname: Weijie surname: Yuan fullname: Yuan, Weijie organization: Department of General Surgery, Xiangya Hospital, Central South University – sequence: 3 givenname: Jin surname: Huang fullname: Huang, Jin organization: Department of Oncology, Xiangya Hospital, Central South University – sequence: 4 givenname: Liyuan surname: Qian fullname: Qian, Liyuan organization: Department of General Surgery, The Third Xiangya Hospital, Central South University – sequence: 5 givenname: Zhikang surname: Chen fullname: Chen, Zhikang organization: Department of General Surgery, Xiangya Hospital, Central South University – sequence: 6 givenname: Jie surname: Ge fullname: Ge, Jie organization: Department of General Surgery, Xiangya Hospital, Central South University – sequence: 7 givenname: Shaobin surname: Wu fullname: Wu, Shaobin organization: Department of General Surgery, Xiangya Hospital, Central South University – sequence: 8 givenname: Jinxiang surname: Chen fullname: Chen, Jinxiang organization: Department of General Surgery, Xiangya Hospital, Central South University – sequence: 9 givenname: Jixu surname: Wang fullname: Wang, Jixu organization: Department of General Surgery, Xiangya Hospital, Central South University – sequence: 10 givenname: Zihua surname: Chen fullname: Chen, Zihua email: chenzihua1@hotmail.com organization: Department of General Surgery, Xiangya Hospital, Central South University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22189617$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kctu1TAQhi1URC_wAGyQJTZsAh47ieNlVZWLVKkbkNhFPj6Tc1wldrB9WrrjHXgKXosnYaIUhJCwZI_l-f7x2P8pOwoxIGPPQbwGIfSbDFIoWQkAmlJX8hE7gaYxFSj4fER71ehKNK04Zqc53wghoZHmCTuWEjrTgj5hP65vMeHXOWHOPgYeB345788ldzElHG3BzO982XOcacXR2_Hnt-8TZgxufz_ZkZdkQ_aFxNUq2PI5xYI-ZO4D39lcknfc2eAwcRu2nOr4tEC7EHOhnJ_mmMoC8CFShk7jjMkWf4t8poCh5Kfs8WDHjM8e4hn79Pby48X76ur63YeL86vKKS1LpehloDurBmhhK6TTWLtu0xnVymHQelNbhKZuG-MGo-hLamNb1VoYHFpErc7Yq7UuNfjlgLn0k88Ox9EGjIfcA42uVY1oCX35D3oTDylQdz0I04AxupZEwUq5FHNOOPRz8pNN9wT1i4_96mNPPvaLj_2iefFQ-bCZcPtH8ds4AuQKZEqFHaa_r_5f1V9Oxa9P |
CODEN | MONCEZ |
CitedBy_id | crossref_primary_10_7314_APJCP_2015_16_7_2777 crossref_primary_10_18632_oncotarget_9802 crossref_primary_10_3892_ol_2019_10677 crossref_primary_10_1007_s11033_020_05767_y crossref_primary_10_1007_s11010_014_2164_6 crossref_primary_10_1111_cas_12556 crossref_primary_10_1016_j_jconrel_2019_08_006 crossref_primary_10_1177_030089161309900608 crossref_primary_10_3390_cancers10030063 crossref_primary_10_1038_s41388_021_01786_6 crossref_primary_10_1021_pr300212g crossref_primary_10_1016_j_mcpro_2021_100131 crossref_primary_10_1016_j_arabjc_2022_104211 crossref_primary_10_1016_j_abb_2021_109024 crossref_primary_10_3892_ol_2014_2196 crossref_primary_10_1007_s00432_018_2683_8 crossref_primary_10_3748_wjg_v20_i34_12313 crossref_primary_10_1002_ijc_27947 crossref_primary_10_1038_s41388_018_0341_x crossref_primary_10_1016_j_prp_2018_07_014 crossref_primary_10_1155_2022_4220786 crossref_primary_10_1186_s40425_019_0679_9 crossref_primary_10_1128_mBio_02892_18 crossref_primary_10_3109_08977194_2014_984806 crossref_primary_10_1007_s12032_012_0305_x crossref_primary_10_1186_s12885_017_3875_3 crossref_primary_10_1111_iep_12219 crossref_primary_10_3748_wjg_v21_i33_9707 crossref_primary_10_1007_s11033_022_08045_1 crossref_primary_10_1007_s00432_021_03618_2 crossref_primary_10_3390_cells9020513 crossref_primary_10_1038_s41419_018_1164_y crossref_primary_10_1016_j_ejca_2013_03_014 crossref_primary_10_3109_08977194_2014_982276 |
Cites_doi | 10.1007/s13277-010-0068-y 10.1136/jcp.2010.076026 10.1007/s10911-010-9178-9 10.1038/modpathol.2009.19 10.1002/cncr.24335 10.1080/00313020701329914 10.1111/j.1872-034X.2009.00563.x 10.1038/nrc822 10.4161/cbt.5.10.3225 10.1158/1078-0432.CCR-0157-03 10.1038/onc.2008.204 10.4161/cbt.7.7.6168 10.1158/0008-5472.CAN-08-4153 10.1158/1078-0432.CCR-09-0473 10.1242/jcs.017145 10.2174/1568009053765780 10.1016/j.cell.2009.11.007 10.1083/jcb.200910041 10.1111/j.1349-7006.2004.tb03194.x 10.1016/S0092-8674(02)00685-2 10.1016/S0140-6736(03)13975-X 10.1387/ijdb.072410mn 10.1016/S0016-5085(97)70218-X 10.1007/s004280000283 10.1002/cncr.22415 10.1016/j.devcel.2009.06.016 10.1371/journal.pone.0012794 10.1007/s12253-008-9132-y 10.1023/A:1006572204497 10.1007/s10555-008-9169-0 10.1111/j.1365-2559.2009.03247.x 10.1007/s10555-008-9179-y 10.1007/s10620-008-0649-4 10.1016/j.ceb.2005.08.001 10.1038/onc.2009.302 10.4161/cbt.5.2.2510 10.1158/1078-0432.CCR-03-0589 10.1002/ijc.24798 10.3748/wjg.v8.i6.987 10.1002/jso.21493 10.4161/cbt.6.2.3629 10.1097/01.sla.0000149300.28588.23 |
ContentType | Journal Article |
Copyright | Springer Science+Business Media, LLC 2011 Springer Science+Business Media New York 2012 |
Copyright_xml | – notice: Springer Science+Business Media, LLC 2011 – notice: Springer Science+Business Media New York 2012 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1007/s12032-011-0127-2 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central AUTh Library subscriptions: ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Academic Eastern Edition MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1559-131X |
EndPage | 2700 |
ExternalDocumentID | 2782371341 10_1007_s12032_011_0127_2 22189617 |
Genre | Research Support, Non-U.S. Gov't Journal Article Feature |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .GJ .VR 06C 06D 0R~ 0VY 2.D 203 28- 29M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 3V. 4.4 406 408 40E 53G 5GY 5RE 5VS 6NX 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AAKSU AANXM AANZL AAPBV AARHV AARTL AATNV AATVU AAUYE AAWCG AAWTL AAYFA AAYIU AAYQN AAYTO ABDZT ABECU ABFGW ABFTV ABHQN ABIPD ABJNI ABJOX ABKAS ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABUWG ABWNU ABXPI ACBMV ACBRV ACBYP ACCUX ACGFS ACHSB ACHVE ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACTTH ACUDM ACVWB ACWMK ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEEQQ AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFAFS AFEXP AFKRA AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGKHE AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GRRUI HF~ HG6 HMCUK HMJXF HRMNR HVGLF HZ~ IJ- IKXTQ IMOTQ IWAJR IXD I~X I~Z J-C J0Z JBSCW JZLTJ KOV LLZTM M1P M4Y MA- N2Q N9A NDZJH NF0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OVD P19 P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 PZZ Q2X QOK QOR QOS R89 R9I RHV RIG RNI ROL RPX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TT1 TUC U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 YLTOR Z7U Z82 Z83 Z87 Z8O Z8V Z91 ZMTXR ZOVNA ZXP ~A9 ~EX AACDK AAEOY AAJBT AASML AAYZH ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU AJOOF ALIPV CGR CUY CVF ECM EIF H13 NPM SJYHP AAYXX CITATION 7XB 8FK K9. PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c372t-3189178a3f161d02c7e4c8b89362ff77b4ae154659cf9300249a636a1fceaee73 |
IEDL.DBID | 7X7 |
ISSN | 1357-0560 |
IngestDate | Fri Oct 25 03:09:43 EDT 2024 Thu Oct 10 18:00:25 EDT 2024 Thu Sep 12 18:03:56 EDT 2024 Tue Oct 15 23:49:04 EDT 2024 Sat Dec 16 12:03:17 EST 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Immunohistochemistry Epithelial–mesenchymal transition Prognosis Gastric cancer EphA2 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c372t-3189178a3f161d02c7e4c8b89362ff77b4ae154659cf9300249a636a1fceaee73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 22189617 |
PQID | 1095199742 |
PQPubID | 30753 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1111863506 proquest_journals_1095199742 crossref_primary_10_1007_s12032_011_0127_2 pubmed_primary_22189617 springer_journals_10_1007_s12032_011_0127_2 |
PublicationCentury | 2000 |
PublicationDate | 2012-12-01 |
PublicationDateYYYYMMDD | 2012-12-01 |
PublicationDate_xml | – month: 12 year: 2012 text: 2012-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Boston |
PublicationPlace_xml | – name: Boston – name: United States – name: Middlesex |
PublicationTitle | Medical oncology (Northwood, London, England) |
PublicationTitleAbbrev | Med Oncol |
PublicationTitleAlternate | Med Oncol |
PublicationYear | 2012 |
Publisher | Springer US Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer Nature B.V |
References | Yang, Yuan, He (CR19) 2009; 39 Dicken, Bigam, Cass (CR2) 2005; 241 Lu, Shahzad, Wang (CR5) 2008; 7 Benjamin, Kwiatkowski, Yang (CR11) 2010; 189 Tomita, van Bokhoven, van Leenders (CR9) 2000; 60 Prudkin, Liu, Ozburn (CR18) 2009; 22 Zhou, Li, Wu (CR31) 2010; 31 Kamat, Coffey, Merritt (CR23) 2009; 115 Brannan, Dong, Prudkin (CR21) 2009; 15 Jawhari, Jordan, Poole (CR16) 1997; 112 Cui, Lee, Yu (CR20) 2010; 126 Fuyuhiro, Yashiro, Noda (CR44) 2010; 30 Zhou, Ran, Tang (CR17) 2007; 6 Thaker, Deavers, Celestino (CR14) 2004; 10 Hsu, Shan, Jin (CR42) 2010; 101 Gilles, Polette, Mestdagt (CR46) 2003; 63 Micalizzi, Farabaugh, Ford (CR8) 2010; 15 Lin, Han, Kamat (CR15) 2007; 109 Almeida, Ferreira, Santos (CR30) 2010; 63 Merrit, Thaker, Landen (CR24) 2006; 5 Schmalhofer, Brabletz, Brabletz (CR10) 2009; 28 Huber, Kraut, Beug (CR13) 2005; 17 Lovatt, Bijlmakers (CR37) 2010; 5 Hess, Seftor, Gardner (CR3) 2001; 61 MacDonald, Tamai, He (CR33) 2009; 17 Wong, Lo, Lee (CR41) 2004; 10 Polette, Gilles, de Bentzmann (CR45) 1998; 16 Thiery, Acloque, Huang (CR7) 2009; 139 Zhou, Xu, Han (CR40) 2002; 8 Hess, Seftor, Gruman (CR48) 2006; 5 Wang, Sun, Allgayer (CR38) 2010; 29 Yilmaz, Christofori (CR29) 2009; 28 Fukuyama, Niculaita, Ng (CR36) 2008; 27 Kataoka, Igarashi, Kanamori (CR25) 2004; 95 Hohenberger, Gretschel (CR1) 2003; 362 Guarino, Rubino, Ballabio (CR32) 2007; 39 Yuan, Ge, Chen (CR49) 2009; 54 Guarino, Rubino, Ballabio (CR26) 2007; 39 Thiery (CR27) 2002; 2 Kim, Lee, Lee (CR43) 2009; 54 Yuan, Chen, Wu (CR6) 2009; 15 Liu, Li, Semenov (CR34) 2002; 108 Fang, Ireton, Zhuang (CR47) 2008; 121 Miyazawa, Iwaya, Kroda (CR39) 2000; 437 Micalizzi, Farabaugh, Ford (CR12) 2010; 15 Nieto (CR28) 2009; 53 Ireton (CR4) 2005; 5 Wang, Fokas, Bieker (CR22) 2008; 19 Song, Mazurek, Liu (CR35) 2009; 69 19101799 - Dig Dis Sci. 2009 Nov;54(11):2410-7 11955436 - Cell. 2002 Mar 22;108(6):837-47 20490631 - J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):117-34 19531623 - Clin Cancer Res. 2009 Jul 1;15(13):4423-30 19048396 - Pathol Oncol Res. 2009 Sep;15(3):473-8 15892616 - Curr Cancer Drug Targets. 2005 May;5(3):149-57 19270647 - Mod Pathol. 2009 May;22(5):668-78 9514091 - Clin Exp Metastasis. 1998 Feb;16(2):105-12 19247945 - Int J Dev Biol. 2009;53(8-10):1541-7 19784072 - Oncogene. 2010 Jan 7;29(1):128-38 19945376 - Cell. 2009 Nov 25;139(5):871-90 20862283 - PLoS One. 2010 Sep 16;5(9):null 15297418 - Clin Cancer Res. 2004 Aug 1;10(15):5145-50 15621988 - Ann Surg. 2005 Jan;241(1):27-39 19396818 - Cancer. 2009 Jun 15;115(12):2684-92 19190323 - Cancer Res. 2009 Feb 15;69(4):1343-9 19309396 - Histopathology. 2009 Mar;54(4):442-51 12439911 - World J Gastroenterol. 2002 Dec;8(6):987-93 11147171 - Virchows Arch. 2000 Nov;437(5):508-13 20563765 - Tumour Biol. 2010 Dec;31(6):549-58 16969087 - Cancer Biol Ther. 2006 Oct;5(10):1357-60 17154180 - Cancer. 2007 Jan 15;109(2):332-40 10910081 - Cancer Res. 2000 Jul 1;60(13):3650-4 14965363 - Cancer Sci. 2004 Feb;95(2):136-41 19169796 - Cancer Metastasis Rev. 2009 Jun;28(1-2):15-33 12892963 - Lancet. 2003 Jul 26;362(9380):305-15 19642143 - Int J Cancer. 2010 Feb 15;126(4):940-9 19788698 - Hepatol Res. 2009 Dec;39(12):1169-77 12750294 - Cancer Res. 2003 May 15;63(10):2658-64 12189386 - Nat Rev Cancer. 2002 Jun;2(6):442-54 18198190 - J Cell Sci. 2008 Feb 1;121(Pt 3):358-68 16098727 - Curr Opin Cell Biol. 2005 Oct;17(5):548-58 20119975 - J Surg Oncol. 2010 Apr 1;101(5):356-62 18443431 - Cancer Biol Ther. 2008 Jul;7(7):1098-103 18097589 - Oncol Rep. 2008 Jan;19(1):151-6 18591935 - Oncogene. 2008 Oct 9;27(46):6044-55 17224647 - Cancer Biol Ther. 2007 Feb;6(2):269-75 19619488 - Dev Cell. 2009 Jul;17(1):9-26 20591914 - J Clin Pathol. 2010 Jul;63(7):635-9 16481735 - Cancer Biol Ther. 2006 Feb;5(2):228-33 21187520 - Anticancer Res. 2010 Dec;30(12):5239-43 20404114 - J Cell Biol. 2010 Apr 19;189(2):339-52 19153669 - Cancer Metastasis Rev. 2009 Jun;28(1-2):151-66 17558857 - Pathology. 2007 Jun;39(3):305-18 14977843 - Clin Cancer Res. 2004 Feb 15;10(4):1401-8 8978342 - Gastroenterology. 1997 Jan;112(1):46-54 11309274 - Cancer Res. 2001 Apr 15;61(8):3250-5 M Yilmaz (127_CR29) 2009; 28 YG Lin (127_CR15) 2007; 109 MA Huber (127_CR13) 2005; 17 PR Almeida (127_CR30) 2010; 63 L Prudkin (127_CR18) 2009; 22 XD Cui (127_CR20) 2010; 126 Q Wang (127_CR38) 2010; 29 S Song (127_CR35) 2009; 69 P Hohenberger (127_CR1) 2003; 362 C Liu (127_CR34) 2002; 108 Y Zhou (127_CR31) 2010; 31 AR Hess (127_CR48) 2006; 5 PH Thaker (127_CR14) 2004; 10 JM Brannan (127_CR21) 2009; 15 AA Kamat (127_CR23) 2009; 115 JM Benjamin (127_CR11) 2010; 189 WM Merrit (127_CR24) 2006; 5 M Guarino (127_CR32) 2007; 39 WJ Yuan (127_CR49) 2009; 54 H Kataoka (127_CR25) 2004; 95 M Lovatt (127_CR37) 2010; 5 YN Zhou (127_CR40) 2002; 8 Y Zhou (127_CR17) 2007; 6 C Gilles (127_CR46) 2003; 63 W Yuan (127_CR6) 2009; 15 HP Hsu (127_CR42) 2010; 101 MA Nieto (127_CR28) 2009; 53 C Lu (127_CR5) 2008; 7 P Yang (127_CR19) 2009; 39 M Polette (127_CR45) 1998; 16 Y Fuyuhiro (127_CR44) 2010; 30 DS Micalizzi (127_CR12) 2010; 15 BJ Dicken (127_CR2) 2005; 241 BT MacDonald (127_CR33) 2009; 17 MA Kim (127_CR43) 2009; 54 A Jawhari (127_CR16) 1997; 112 RC Ireton (127_CR4) 2005; 5 K Miyazawa (127_CR39) 2000; 437 M Guarino (127_CR26) 2007; 39 JP Thiery (127_CR27) 2002; 2 K Tomita (127_CR9) 2000; 60 DS Micalizzi (127_CR8) 2010; 15 AR Hess (127_CR3) 2001; 61 R Fukuyama (127_CR36) 2008; 27 LF Wang (127_CR22) 2008; 19 SC Wong (127_CR41) 2004; 10 WB Fang (127_CR47) 2008; 121 O Schmalhofer (127_CR10) 2009; 28 JP Thiery (127_CR7) 2009; 139 |
References_xml | – volume: 31 start-page: 549 year: 2010 end-page: 558 ident: CR31 article-title: Clinicopathological significance of E-cadherin, VEGF, and MMPs in gastric cancer publication-title: Tumour Biol doi: 10.1007/s13277-010-0068-y contributor: fullname: Wu – volume: 63 start-page: 635 year: 2010 end-page: 639 ident: CR30 article-title: E-cadherin immunoexpression patterns in the characterisation of gastric carcinoma histotypes publication-title: J Clin Pathol doi: 10.1136/jcp.2010.076026 contributor: fullname: Santos – volume: 15 start-page: 117 year: 2010 end-page: 134 ident: CR12 article-title: Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression publication-title: J Mammary Gland Biol Neoplasia. doi: 10.1007/s10911-010-9178-9 contributor: fullname: Ford – volume: 22 start-page: 668 year: 2009 end-page: 678 ident: CR18 article-title: Epithelial–mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung publication-title: Mod Pathol. doi: 10.1038/modpathol.2009.19 contributor: fullname: Ozburn – volume: 126 start-page: 940 year: 2010 end-page: 949 ident: CR20 article-title: EFNA1 ligand and its receptor EphA2: potential biomarkers for hepatocellular carcinoma publication-title: Int J Cancer contributor: fullname: Yu – volume: 115 start-page: 2684 year: 2009 end-page: 2692 ident: CR23 article-title: EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer publication-title: Cancer. doi: 10.1002/cncr.24335 contributor: fullname: Merritt – volume: 39 start-page: 305 year: 2007 end-page: 318 ident: CR26 article-title: The role of epithelial-mesenchymal transition in cancer pathology publication-title: Pathology. doi: 10.1080/00313020701329914 contributor: fullname: Ballabio – volume: 39 start-page: 1169 year: 2009 end-page: 1177 ident: CR19 article-title: Overexpression of EphA2, MMP-9 and MVD-CD34 in hepatocellular carcinoma: implications for tumor progression and prognosis publication-title: Heptol Res. doi: 10.1111/j.1872-034X.2009.00563.x contributor: fullname: He – volume: 2 start-page: 442 year: 2002 end-page: 454 ident: CR27 article-title: Epithelial-mesenchymal transition in tumor progression publication-title: Nat Rev Cancer doi: 10.1038/nrc822 contributor: fullname: Thiery – volume: 39 start-page: 305 year: 2007 end-page: 318 ident: CR32 article-title: The role of epithelial–mesenchymal transition in cancer pathology publication-title: Pathology. doi: 10.1080/00313020701329914 contributor: fullname: Ballabio – volume: 5 start-page: 1357 year: 2006 end-page: 1360 ident: CR24 article-title: Analysis of EphA2 expression and mutant p53 in ovarian carcinoma publication-title: Cancer Biol Ther doi: 10.4161/cbt.5.10.3225 contributor: fullname: Landen – volume: 10 start-page: 1401 year: 2004 end-page: 1408 ident: CR41 article-title: Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-0157-03 contributor: fullname: Lee – volume: 27 start-page: 6044 year: 2008 end-page: 6055 ident: CR36 article-title: Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription publication-title: Oncogene. doi: 10.1038/onc.2008.204 contributor: fullname: Ng – volume: 8 start-page: 987 year: 2002 end-page: 993 ident: CR40 article-title: Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival publication-title: World J Gastroenterol contributor: fullname: Han – volume: 61 start-page: 3250 year: 2001 end-page: 3255 ident: CR3 article-title: Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2) publication-title: Cancer Res contributor: fullname: Gardner – volume: 7 start-page: 1098 year: 2008 end-page: 1103 ident: CR5 article-title: EphA2 overexpression promotes ovarian cancer growth publication-title: Cancer Biol Ther doi: 10.4161/cbt.7.7.6168 contributor: fullname: Wang – volume: 69 start-page: 1343 year: 2009 end-page: 1349 ident: CR35 article-title: Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-4153 contributor: fullname: Liu – volume: 15 start-page: 4423 year: 2009 end-page: 4430 ident: CR21 article-title: Expression of the receptor tyrosine kinase EphA2 is increased in smokers and predicts poor survival in non-small cell lung cancer publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-09-0473 contributor: fullname: Prudkin – volume: 121 start-page: 358 year: 2008 end-page: 368 ident: CR47 article-title: Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism publication-title: J Cell Sci doi: 10.1242/jcs.017145 contributor: fullname: Zhuang – volume: 101 start-page: 356 year: 2010 end-page: 362 ident: CR42 article-title: Loss of E-cadherin and beta-catenin is correlated with poor prognosis of ampullary neoplasms publication-title: J Surg Oncol contributor: fullname: Jin – volume: 5 start-page: 149 year: 2005 end-page: 157 ident: CR4 article-title: Chen J: EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics publication-title: Curr Cancer Drug Targets. doi: 10.2174/1568009053765780 contributor: fullname: Ireton – volume: 139 start-page: 871 year: 2009 end-page: 890 ident: CR7 article-title: Epithelial–mesenchymal transitions in development and disease publication-title: Cell doi: 10.1016/j.cell.2009.11.007 contributor: fullname: Huang – volume: 189 start-page: 339 year: 2010 end-page: 352 ident: CR11 article-title: AlphaE-catenin regulates actin dynamics independently of cadherin-mediated cell–cell adhesion publication-title: J Cell Biol doi: 10.1083/jcb.200910041 contributor: fullname: Yang – volume: 95 start-page: 136 year: 2004 end-page: 141 ident: CR25 article-title: Correlation of EPHA2 overexpression with high microvessel count in human primary colorectal cancer publication-title: Cancer Sci doi: 10.1111/j.1349-7006.2004.tb03194.x contributor: fullname: Kanamori – volume: 60 start-page: 3650 year: 2000 end-page: 3654 ident: CR9 article-title: Cadherin switching in human prostate cancer progression publication-title: Cancer Res contributor: fullname: van Leenders – volume: 241 start-page: 27 year: 2005 end-page: 39 ident: CR2 article-title: Gastric adenocarcinoma: review and considerations for future directions publication-title: Ann Surg contributor: fullname: Cass – volume: 108 start-page: 837 year: 2002 end-page: 847 ident: CR34 article-title: Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism publication-title: Cell doi: 10.1016/S0092-8674(02)00685-2 contributor: fullname: Semenov – volume: 63 start-page: 2658 year: 2003 end-page: 2664 ident: CR46 article-title: Transactivation of vimentin by beta-catenin in human breast cancer cells publication-title: Cancer Res contributor: fullname: Mestdagt – volume: 362 start-page: 305 year: 2003 end-page: 315 ident: CR1 article-title: Gastric cancer publication-title: Lancet doi: 10.1016/S0140-6736(03)13975-X contributor: fullname: Gretschel – volume: 53 start-page: 1541 year: 2009 end-page: 1547 ident: CR28 article-title: Epithelial–mesenchymal transitions in development and disease: old views and new perspectives publication-title: Int J Dev Biol doi: 10.1387/ijdb.072410mn contributor: fullname: Nieto – volume: 112 start-page: 46 year: 1997 end-page: 54 ident: CR16 article-title: Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival publication-title: Gastroenterology doi: 10.1016/S0016-5085(97)70218-X contributor: fullname: Poole – volume: 437 start-page: 508 year: 2000 end-page: 513 ident: CR39 article-title: Nuclear accumulation of beta-catenin in intestinal-type gastric carcinoma: correlation with early tumor invasion publication-title: Virchows Arch doi: 10.1007/s004280000283 contributor: fullname: Kroda – volume: 109 start-page: 332 year: 2007 end-page: 340 ident: CR15 article-title: EphA2 overexpression is associated with angiogenesis in ovarian cancer publication-title: Cancer. doi: 10.1002/cncr.22415 contributor: fullname: Kamat – volume: 17 start-page: 9 year: 2009 end-page: 26 ident: CR33 article-title: Wnt/beta-catenin signaling: components, mechanisms, and diseases publication-title: Dev Cell. doi: 10.1016/j.devcel.2009.06.016 contributor: fullname: He – volume: 5 start-page: e12794 year: 2010 ident: CR37 article-title: Stabilisation of β-catenin downstream of T cell receptor signaling publication-title: PLoS One. doi: 10.1371/journal.pone.0012794 contributor: fullname: Bijlmakers – volume: 15 start-page: 473 year: 2009 end-page: 478 ident: CR6 article-title: Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis publication-title: Pathol Oncol Res. doi: 10.1007/s12253-008-9132-y contributor: fullname: Wu – volume: 30 start-page: 5239 year: 2010 end-page: 5243 ident: CR44 article-title: Clinical significance of vimentin-positive gastric cancer cells publication-title: Anticancer Res contributor: fullname: Noda – volume: 6 start-page: 269 year: 2007 end-page: 275 ident: CR17 article-title: Effect of celecoxib on E-cadherin, VEGF. Microvessel density and apoptosis in gastric cancer publication-title: Cancer Biol Ther. contributor: fullname: Tang – volume: 16 start-page: 105 year: 1998 end-page: 112 ident: CR45 article-title: Association of fibroblastoid features with the invasive phenotype in human bronchial cancer cell lines publication-title: Clin Exp Metastasis doi: 10.1023/A:1006572204497 contributor: fullname: de Bentzmann – volume: 28 start-page: 15 year: 2009 end-page: 33 ident: CR29 article-title: EMT, the cytoskeleton, and cancer cell invasion publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-008-9169-0 contributor: fullname: Christofori – volume: 15 start-page: 117 year: 2010 end-page: 134 ident: CR8 article-title: Epithelial–mesenchymal transition in cancer: parallels between normal development and tumor progression publication-title: J Mammary Gland Biol Neoplasia. doi: 10.1007/s10911-010-9178-9 contributor: fullname: Ford – volume: 19 start-page: 151 year: 2008 end-page: 156 ident: CR22 article-title: Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients publication-title: Oncol Rep contributor: fullname: Bieker – volume: 54 start-page: 442 year: 2009 end-page: 451 ident: CR43 article-title: Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma publication-title: Histopathology doi: 10.1111/j.1365-2559.2009.03247.x contributor: fullname: Lee – volume: 28 start-page: 151 year: 2009 end-page: 166 ident: CR10 article-title: E-cadherin beta-catenin and ZEB1 in malignant progression of cancer publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-008-9179-y contributor: fullname: Brabletz – volume: 54 start-page: 2410 year: 2009 end-page: 2417 ident: CR49 article-title: Over-expression of EphA2 and EphrinA-1 in human gastric adenocarcinoma and its prognostic value for postoperative patients publication-title: Dig Dis Sci doi: 10.1007/s10620-008-0649-4 contributor: fullname: Chen – volume: 17 start-page: 548 year: 2005 end-page: 558 ident: CR13 article-title: Molecular requirements for epithelial-mesenchymal transition during tumor progression publication-title: Curr Opin Cell Biol doi: 10.1016/j.ceb.2005.08.001 contributor: fullname: Beug – volume: 29 start-page: 128 year: 2010 end-page: 138 ident: CR38 article-title: Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells publication-title: Oncogene. doi: 10.1038/onc.2009.302 contributor: fullname: Allgayer – volume: 5 start-page: 228 year: 2006 end-page: 233 ident: CR48 article-title: VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry publication-title: Cancer Biol Ther doi: 10.4161/cbt.5.2.2510 contributor: fullname: Gruman – volume: 10 start-page: 5145 year: 2004 end-page: 5150 ident: CR14 article-title: EphA2 expression is associated with aggressive features in ovarian carcinoma publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-03-0589 contributor: fullname: Celestino – volume: 5 start-page: 149 year: 2005 ident: 127_CR4 publication-title: Curr Cancer Drug Targets. doi: 10.2174/1568009053765780 contributor: fullname: RC Ireton – volume: 7 start-page: 1098 year: 2008 ident: 127_CR5 publication-title: Cancer Biol Ther doi: 10.4161/cbt.7.7.6168 contributor: fullname: C Lu – volume: 5 start-page: e12794 year: 2010 ident: 127_CR37 publication-title: PLoS One. doi: 10.1371/journal.pone.0012794 contributor: fullname: M Lovatt – volume: 126 start-page: 940 year: 2010 ident: 127_CR20 publication-title: Int J Cancer doi: 10.1002/ijc.24798 contributor: fullname: XD Cui – volume: 95 start-page: 136 year: 2004 ident: 127_CR25 publication-title: Cancer Sci doi: 10.1111/j.1349-7006.2004.tb03194.x contributor: fullname: H Kataoka – volume: 39 start-page: 1169 year: 2009 ident: 127_CR19 publication-title: Heptol Res. doi: 10.1111/j.1872-034X.2009.00563.x contributor: fullname: P Yang – volume: 108 start-page: 837 year: 2002 ident: 127_CR34 publication-title: Cell doi: 10.1016/S0092-8674(02)00685-2 contributor: fullname: C Liu – volume: 10 start-page: 1401 year: 2004 ident: 127_CR41 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-0157-03 contributor: fullname: SC Wong – volume: 139 start-page: 871 year: 2009 ident: 127_CR7 publication-title: Cell doi: 10.1016/j.cell.2009.11.007 contributor: fullname: JP Thiery – volume: 8 start-page: 987 year: 2002 ident: 127_CR40 publication-title: World J Gastroenterol doi: 10.3748/wjg.v8.i6.987 contributor: fullname: YN Zhou – volume: 54 start-page: 2410 year: 2009 ident: 127_CR49 publication-title: Dig Dis Sci doi: 10.1007/s10620-008-0649-4 contributor: fullname: WJ Yuan – volume: 437 start-page: 508 year: 2000 ident: 127_CR39 publication-title: Virchows Arch doi: 10.1007/s004280000283 contributor: fullname: K Miyazawa – volume: 61 start-page: 3250 year: 2001 ident: 127_CR3 publication-title: Cancer Res contributor: fullname: AR Hess – volume: 28 start-page: 151 year: 2009 ident: 127_CR10 publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-008-9179-y contributor: fullname: O Schmalhofer – volume: 39 start-page: 305 year: 2007 ident: 127_CR32 publication-title: Pathology. doi: 10.1080/00313020701329914 contributor: fullname: M Guarino – volume: 16 start-page: 105 year: 1998 ident: 127_CR45 publication-title: Clin Exp Metastasis doi: 10.1023/A:1006572204497 contributor: fullname: M Polette – volume: 189 start-page: 339 year: 2010 ident: 127_CR11 publication-title: J Cell Biol doi: 10.1083/jcb.200910041 contributor: fullname: JM Benjamin – volume: 15 start-page: 4423 year: 2009 ident: 127_CR21 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-09-0473 contributor: fullname: JM Brannan – volume: 27 start-page: 6044 year: 2008 ident: 127_CR36 publication-title: Oncogene. doi: 10.1038/onc.2008.204 contributor: fullname: R Fukuyama – volume: 30 start-page: 5239 year: 2010 ident: 127_CR44 publication-title: Anticancer Res contributor: fullname: Y Fuyuhiro – volume: 362 start-page: 305 year: 2003 ident: 127_CR1 publication-title: Lancet doi: 10.1016/S0140-6736(03)13975-X contributor: fullname: P Hohenberger – volume: 109 start-page: 332 year: 2007 ident: 127_CR15 publication-title: Cancer. doi: 10.1002/cncr.22415 contributor: fullname: YG Lin – volume: 39 start-page: 305 year: 2007 ident: 127_CR26 publication-title: Pathology. doi: 10.1080/00313020701329914 contributor: fullname: M Guarino – volume: 22 start-page: 668 year: 2009 ident: 127_CR18 publication-title: Mod Pathol. doi: 10.1038/modpathol.2009.19 contributor: fullname: L Prudkin – volume: 112 start-page: 46 year: 1997 ident: 127_CR16 publication-title: Gastroenterology doi: 10.1016/S0016-5085(97)70218-X contributor: fullname: A Jawhari – volume: 15 start-page: 117 year: 2010 ident: 127_CR8 publication-title: J Mammary Gland Biol Neoplasia. doi: 10.1007/s10911-010-9178-9 contributor: fullname: DS Micalizzi – volume: 53 start-page: 1541 year: 2009 ident: 127_CR28 publication-title: Int J Dev Biol doi: 10.1387/ijdb.072410mn contributor: fullname: MA Nieto – volume: 17 start-page: 9 year: 2009 ident: 127_CR33 publication-title: Dev Cell. doi: 10.1016/j.devcel.2009.06.016 contributor: fullname: BT MacDonald – volume: 15 start-page: 473 year: 2009 ident: 127_CR6 publication-title: Pathol Oncol Res. doi: 10.1007/s12253-008-9132-y contributor: fullname: W Yuan – volume: 10 start-page: 5145 year: 2004 ident: 127_CR14 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-03-0589 contributor: fullname: PH Thaker – volume: 2 start-page: 442 year: 2002 ident: 127_CR27 publication-title: Nat Rev Cancer doi: 10.1038/nrc822 contributor: fullname: JP Thiery – volume: 101 start-page: 356 year: 2010 ident: 127_CR42 publication-title: J Surg Oncol doi: 10.1002/jso.21493 contributor: fullname: HP Hsu – volume: 15 start-page: 117 year: 2010 ident: 127_CR12 publication-title: J Mammary Gland Biol Neoplasia. doi: 10.1007/s10911-010-9178-9 contributor: fullname: DS Micalizzi – volume: 54 start-page: 442 year: 2009 ident: 127_CR43 publication-title: Histopathology doi: 10.1111/j.1365-2559.2009.03247.x contributor: fullname: MA Kim – volume: 31 start-page: 549 year: 2010 ident: 127_CR31 publication-title: Tumour Biol doi: 10.1007/s13277-010-0068-y contributor: fullname: Y Zhou – volume: 115 start-page: 2684 year: 2009 ident: 127_CR23 publication-title: Cancer. doi: 10.1002/cncr.24335 contributor: fullname: AA Kamat – volume: 63 start-page: 635 year: 2010 ident: 127_CR30 publication-title: J Clin Pathol doi: 10.1136/jcp.2010.076026 contributor: fullname: PR Almeida – volume: 17 start-page: 548 year: 2005 ident: 127_CR13 publication-title: Curr Opin Cell Biol doi: 10.1016/j.ceb.2005.08.001 contributor: fullname: MA Huber – volume: 121 start-page: 358 year: 2008 ident: 127_CR47 publication-title: J Cell Sci doi: 10.1242/jcs.017145 contributor: fullname: WB Fang – volume: 29 start-page: 128 year: 2010 ident: 127_CR38 publication-title: Oncogene. doi: 10.1038/onc.2009.302 contributor: fullname: Q Wang – volume: 69 start-page: 1343 year: 2009 ident: 127_CR35 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-4153 contributor: fullname: S Song – volume: 63 start-page: 2658 year: 2003 ident: 127_CR46 publication-title: Cancer Res contributor: fullname: C Gilles – volume: 28 start-page: 15 year: 2009 ident: 127_CR29 publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-008-9169-0 contributor: fullname: M Yilmaz – volume: 5 start-page: 228 year: 2006 ident: 127_CR48 publication-title: Cancer Biol Ther doi: 10.4161/cbt.5.2.2510 contributor: fullname: AR Hess – volume: 6 start-page: 269 year: 2007 ident: 127_CR17 publication-title: Cancer Biol Ther. doi: 10.4161/cbt.6.2.3629 contributor: fullname: Y Zhou – volume: 19 start-page: 151 year: 2008 ident: 127_CR22 publication-title: Oncol Rep contributor: fullname: LF Wang – volume: 5 start-page: 1357 year: 2006 ident: 127_CR24 publication-title: Cancer Biol Ther doi: 10.4161/cbt.5.10.3225 contributor: fullname: WM Merrit – volume: 60 start-page: 3650 year: 2000 ident: 127_CR9 publication-title: Cancer Res contributor: fullname: K Tomita – volume: 241 start-page: 27 year: 2005 ident: 127_CR2 publication-title: Ann Surg doi: 10.1097/01.sla.0000149300.28588.23 contributor: fullname: BJ Dicken |
SSID | ssj0021529 |
Score | 2.2211497 |
Snippet | The expression of EphA2 and three epithelial–mesenchymal transition-related proteins (E-cadherin, β-catenin and vimentin) was detected by immunohistochemistry... The expression of EphA2 and three epithelial-mesenchymal transition-related proteins (E-cadherin, β-catenin and vimentin) was detected by immunohistochemistry... |
SourceID | proquest crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 2691 |
SubjectTerms | Adult Aged beta Catenin - analysis Cadherins - analysis Epithelial-Mesenchymal Transition Female Hematology Humans Internal Medicine Lymphatic Metastasis Male Medicine Medicine & Public Health Middle Aged Neoplasm Staging Oncology Original Paper Pathology Prognosis Receptor, EphA2 - analysis Receptor, EphA2 - physiology Stomach Neoplasms - chemistry Stomach Neoplasms - mortality Stomach Neoplasms - pathology Stomach Neoplasms - surgery Vimentin - analysis |
SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NbtQwELaqIqFeEBQKC6UaJE5UrrKO194cV6hVVanthZV6i8aOQ1d0vVF3K8GNd-ApeC2ehBknm1KVHnqOY1v6xp5vPH9CfCSWWyjMnDTaBqm1R-lsVkiPrlJ1XeHIcHLy6Zk5nuqTi9HFhlD900X8drD2SKaL-jbXjXt9y_SiN1RW0rX7hLiD5jCuqZr0RhbpoyIZWSMrSbn3nsz_TXFXF90jmPeco0nnHD0XzzqyCJMW3RdiI8Rt8fS0c4e_FL_PSRDD9y6WNcKihsPmcqLAc8-NK6aRwA-tEBpOvbgiWfvz89ecE4785Y85Tb1iVZWitmT7QwWpcsMsLmEW4StyWw8PnmXjGjBWkDwLPIgj9GhfMJsnCk8DgAgwNFypowltQXHoyrYuX4np0eGXz8ey670gfW7VipOqyZAbY14TJawy5W3QfuyI3RiC0FqnMQy5kXrh6yJPhQfR5AaHtQ8Ygs13xGZcxPBGAF2gPnOoQ65Rj43BzLsKC2-r3DvMzUB8WqNQNm2JjfK2mDJDVhJkJUNWqoHYXeNUdqdtyV70EQfMaPr8of9M54SdHxjD4maZLJ0xsauM1nvd4tuvpojnFETlBmJ_Dfi_kz-wlbePGv1ObBHXUm0kzK7YXF3fhPfEZ1ZuLwnwX7z88hc priority: 102 providerName: Springer Nature |
Title | Overexpression of EphA2 correlates with epithelial–mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients |
URI | https://link.springer.com/article/10.1007/s12032-011-0127-2 https://www.ncbi.nlm.nih.gov/pubmed/22189617 https://www.proquest.com/docview/1095199742 https://search.proquest.com/docview/1111863506 |
Volume | 29 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fa9swEBdd-7KXsdJ1y9aWG-xpQ-DIihQ_jaykLSttx2ggezInWV4DjePVKWyfaF9zd7KTrJTtyWALSfhOut_9F-IdodxMYeKk0TZIrT1KZ5NMenSFKssCB4aTky8uzdlEf54Opp3BrenCKld3Yryoi4VnGzmdbsICGaFf9bH-IblrFHtXuxYaT8ROXxHzEj_b6UbhItmURYVrYCUJ-rVXM6bOcetwGQ2EfWWleiiXHoHNR47SKH9OnotnHXCEUUvpXbEVqj3x-4o4MfzsglkrWJQwrm9GCjw33bhlHAlsaYVQc-7FLTGbnHO-kb_5NafZliypYtCWbIcXEAs3zKoGZhV8R-7q4cEza9wBVgVExwIP4gA92grM5hHB0wAg_As1F-qoQ1tPHLqqrc0LMTkZXx-fya71gvSpVUvOqSY9bohpSYiwSJS3QfuhI3BjiILWOo2hz33UM19maaw7iCY12C99wBBsui-2q0UVXgmg-9MnDnVINeqhMZh4V2DmbZF6h6npiferH5_XbYWNfFNLmamUE5VyplKueuJgRZq8O2xNvmGNnni7_kzHhH0fWIXFfRMVnSGBq4TWe9mSdL2aIpiTEZLriQ8rGv89-T-28vr_W3kjnhK2Um3ky4HYXt7dh0PCL0t3FJn0SOyMTr-dj-n5aXz55Su9najRHxb39T8 |
link.rule.ids | 315,783,787,12070,21402,27938,27939,31733,31734,33758,33759,41095,41537,42164,42606,43324,43819,52125,52248,74081,74638 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Rb9MwELZgPMALAjGgMLZD4mnIUuq4dvOEJrSp29rxskl9i86OwyqtaWhaCX4Rf5M7J22HJniOZVu5s-873913QnwilJspTJw02gaptUfpbJJJj65QZVngwHBx8uTKjG70xXQw7R7cmi6tcnMnxou6WHh-I6fTTVggI_SrvtQ_JHeN4uhq10LjsXjCPFzMnW-nO4eLbFMWHa6BlWTot1HNWDrHrcNlfCDsKyvV33bpAdh8ECiN9ufshXjeAUc4aSX9UjwK1Svx-xtpYvjZJbNWsCjhtL49UeC56cYd40jgl1YINdde3JGyyTnXG_nbX3OabcWWKiZtyXZ4AZG4YVY1MKvgO3JXDw-eVWMJWBUQAws8iBP0aCswm0cETwOA8C_UTNRRh5ZPHDrW1mZf3JydXn8dya71gvSpVSuuqSY_bohpSYiwSJS3QfuhI3BjSILWOo2hz33UM19maeQdRJMa7Jc-YAg2fS32qkUV3gqg-9MnDnVINeqhMZh4V2DmbZF6h6npiePNj8_rlmEj33Eps5RyklLOUspVTxxsRJN3h63Jd6rREx-3n-mYcOwDq7BYN9HRGRK4Smi9N61It6spgjkZIbme-LyR8f3J_7GVd__fypF4OrqejPPx-dXle_GMcJZqs2AOxN5quQ4fCMus3GFU2D-wqvQY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxELZokVAvCFQeKQUGiRPIYuN17OwJVdCoDygcqJTbauz1tpGazdJNJfhF_E1mvE4CquC8lm3tN_Z843kJ8ZpYbqEwc9JoG6TWHqWzWSE9ukrVdYUjw8nJn8_M0bk-mY6mKf6pS2GVqzsxXtTVwvMbOZ1u4gIFsV_1rk5hEV8_Tt633yV3kGJPa2qnsSXuWk2KjmTbTjfGF-mpIhpfIytJ6a89nDGNjtuIy_hYOFRWqr911C3iectpGnXR5IG4n0gkHPSoPxR3QrMrfn0hqQw_UmBrA4saDtvLAwWeG3BcMacEfnWF0HIexhUJnpxz7pG__Dmn2ZastWIAl-yHVxCLOMyaDmYNXCB3-PDgWUyuAZsKopOBB3GwHm0FZvPI5mkAEBeGlot2tKGvLQ6pgmv3SJxPDr99OJKpDYP0uVVLzq8mm26MeU3ssMqUt0H7sSOiYwhNa53GMOSe6oWvizzWIESTGxzWPmAINn8stptFE54KoLvUZw51yDXqsTGYeVdh4W2Ve4e5GYg3qx9ftn21jXJTV5lRKgmlklEq1UDsr6Ap08Hryo2YDMSr9Wc6MuwHwSYsbrpo9IyJaGW03pMe0vVqiihPQaxuIN6uMP5z8n9sZe__W3kp7pGslp-Oz06fiR2iXKoPiNkX28vrm_CcaM3SvYjy-hsDGPhN |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Overexpression+of+EphA2+correlates+with+epithelial-mesenchymal+transition-related+proteins+in+gastric+cancer+and+their+prognostic+importance+for+postoperative+patients&rft.jtitle=Medical+oncology+%28Northwood%2C+London%2C+England%29&rft.au=Hou%2C+Futao&rft.au=Yuan%2C+Weijie&rft.au=Huang%2C+Jin&rft.au=Qian%2C+Liyuan&rft.date=2012-12-01&rft.eissn=1559-131X&rft.volume=29&rft.issue=4&rft.spage=2691&rft.epage=2700&rft_id=info:doi/10.1007%2Fs12032-011-0127-2&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1357-0560&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1357-0560&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1357-0560&client=summon |